Benjamin Miron MD
Genitourinary Oncology
Instructor at Fox Chase Cancer Center
Join to View Full Profile
333 Cottman AvePhiladelphia, PA 19111
Dr. Miron is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Fox Chase Cancer CenterHematology and Medical Oncology, 2019 - 2024
Temple University HospitalResidency, Internal Medicine, 2017 - 2019
New York University School of MedicineClass of 2019- New York University School of MedicineOther MD/DO, 2019
- New York University School of MedicineClass of 2014
Certifications & Licensure
PA State Medical License 2017 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Survival Outcomes in Patients With Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy Stratified by Number of Cycles.Anumita Chakraborty, Jill Hasler, Elizabeth Handorf, Fern Anari, Pooja Ghatalia
Clinical Genitourinary Cancer. 2024-12-01 - Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the JAVELIN Bladder 100 comprehensive clinical subgroup ana...Kevin K Zarrabi, Benjamin Miron, Daniel M Geynisman
Translational Andrology and Urology. 2024-03-31 - 2 citationsThe Genomic Landscape of Urothelial Carcinoma with High and LowExpression.Agreen Hadadi, Harris B Krause, Andrew Elliott, Jacqueline T Brown, Bassel Nazha
Cancers. 2023-12-06
Press Mentions
Five Cancer Researchers Receive 2021 New Discoveries Young Investigator Awards from BCANMay 28th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
